THE SHARE: Change: +0.01 SEK (+7.43%) / Price: 0.11 SEK / Apr 2, 2026, 12:59 pm (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

Spago Nanomedical in media

  • 27 Sep, 2017
    Spago Nanomedical presentation på Redeye Early Bird
  • 11 Sep, 2017
    FDA votes for further warnings for gadolinium-based contrast agents
  • 11 Sep, 2017
    FDA röstar för utökade varningar för gadoliniumbaserade kontrastmedel
  • 29 Aug, 2017
    Production process ready for transfer to GMP manufacture
  • 29 Aug, 2017
    Tillverkningsprocess redo för överföring till GMP-produktion
  • 15 Aug, 2017
    Spago granted SME-designation by EMA
  • 15 Aug, 2017
    Spago beviljas SME-status hos EMA
  • 11 Jul, 2017
    PRAC confirms restrictions on the use of linear gadolinium agents
  • 11 Jul, 2017
    PRAC vidhåller restriktioner kring gadolinium-kontrastmedel
  • 22 Jun, 2017
    Video från presentation på Småbolagsdagen
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 19
  • Previous
  • Next
Back
  • Spago Nanomedical in media
  • Press Releases
  • Subscribe
  • Presentations
  • Events
  • Image Bank

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2026 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications